204072-53-7

Upstream product

• 58929-72-9 bis(3-bromopropyl) ether 
• 874130-97-9 methylsulphoxide 
• 108-95-2 phenol 

Downstream Products

• 215448-55-8 N-[1-(4-Amino-thieno[3,2-c]pyridin-2-ylmethyl)-2-(4-methyl-piperidin-1-yl)-2-oxo-ethyl]-4-(2-methoxy-ethoxy)-benzenesulfonamide 
• 253194-78-4 (S)-4-[4-(2-Methoxy-ethoxy)-benzenesulfonyl]-2,2-dimethyl-[1,4]thiazepane-3-carboxylic acid 
• 1053698-38-6 (2R,4S)-4-(2,5-Dioxo-3-propyl-imidazolidin-1-yl)-1-[4-(2-methoxy-ethoxy)-benzenesulfonyl]-pyrrolidine-2-carboxylic acid methyl ester 
• 204072-99-1 (2R,4S)-1-[4-(2-Methoxy-ethoxy)-benzenesulfonyl]-4-(3-methyl-2,5-dioxo-imidazolidin-1-yl)-pyrrolidine-2-carboxylic acid methyl ester 
• 204072-54-8 (2R,4R)-4-Hydroxy-1-[4-(2-methoxy-ethoxy)-benzenesulfonyl]-pyrrolidine-2-carboxylic acid methyl ester 
• 1026536-09-3 (R)-1-[4-(2-Methoxy-ethoxy)-benzenesulfonyl]-4-methylene-pyrrolidine-2-carboxylic acid methyl ester 

Relevant academic research and scientific papers

Substituted cyclic amine metalloprotease inhibitors

The invention provides compounds which are useful as inhibitors of metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the present invention relates to a compound having a stru

Substituted cyclic amine metalloprotease inhibitors

The invention provides compounds according to Formula (I): which are useful as inhibitors of metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes.

Substituted cyclic amine metalloprotease inhibitors

The invention provides compounds which are useful as inhibitors of metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the present invention relates to a compound having a stru

Keratinocyte growth inhibitors and hydroxamic acid derivatives

This invention relates to a keratinocyte-proliferation inhibitor comprising as active ingredient a compound having an activity of inhibiting the solubilization of heparin-binding EGF-like growth factor bound to cell membranes and a compound of the formula (I); or pharmaceutically acceptable salt thereof, wherein R1, R2, R3 are hydrogen atom or alkyl and X is substituted benzene or the like.

Substituted cyclic amine metalloprotease inhibitors

The invention provides compounds which are useful as inhibitors of metalloproteases, and which are effective in treating conditions characterized by excess activity of these enzymes. In particular, the present invention relates to a compound having a stru